Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.4.2.1 extracted from

  • Pereira, H.M.; Berdini, V.; Ferri, M.R.; Cleasby, A.; Garratt, R.C.
    Crystal structure of Schistosoma purine nucleoside phosphorylase complexed with a novel monocyclic inhibitor (2010), Acta Trop., 114, 97-102.
    View publication on PubMed

Crystallization (Commentary)

Crystallization (Comment) Organism
in complex with inhibitor 6-amino-5-bromopyrimidine-2,4(1H,3H)-dione, to 1.9 A resolution Schistosoma mansoni

Inhibitors

Inhibitors Comment Organism Structure
1-[4-(2,4-dimethylphenyl)-1,3-thiazol-2-yl]guanidine 0.1 mM , 79.5% inhibition Schistosoma mansoni
1-[4-(4-methylphenyl)-1,3-thiazol-2-yl]guanidine 0.1 mM , 70.6% inhibition Schistosoma mansoni
6-amino-5-bromopyrimidine-2,4(1H,3H)-dione formation of eight hydrogen bonds with key residues in the active site E203, N245 and T244 Schistosoma mansoni

Organism

Organism UniProt Comment Textmining
Schistosoma mansoni Q9BMI9
-
-

IC50 Value

IC50 Value IC50 Value Maximum Comment Organism Inhibitor Structure
0.0013
-
pH 7.0 Schistosoma mansoni 6-amino-5-bromopyrimidine-2,4(1H,3H)-dione